Sandu Pharmaceuticals informs about closure of trading window

24 Sep 2025 Evaluate

Pursuant to the ‘Code of Conduct for Prevention of Insider Trading’ of the Company, SEBI (Prohibition of Insider Trading) Regulations, 2015 and clarification given by BSE vide its letter ref no LIST/COMP/01/2019-20 dated April 2,2019 regarding trading restrictions period, Sandu Pharmaceuticals has informed that the trading window for dealing in Securities of the Company shall remain closed from Wednesday, 01st October 2025 till 48 hours after the declaration of the financial results of the Company for the quarter ended 30th September 2025 for Directors, KMPs, Promoters And Promoters Group and Designated Persons ,Immediate Relative etc covered under the Code. The date of the Board Meeting for consideration of the Unaudited Financial Results of the Company for the quarter ended 30th September 2025 will be intimated in due course. Accordingly, all Designated Persons and their immediate relatives are advised not to trade in the securities of the Company during the aforesaid trading window closure period.

The above information is a part of company’s filings submitted to BSE.

Sandu Pharmaceutical Share Price

39.50 -0.70 (-1.74%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×